Systemic absorption of 14C-radiolabelled sertaconazole administered in 300 mg prolonged-liberation vaginal suppository form to four healthy post-menopausal women

Journal de Mycologie Medicale

Volumn 6, Issue 2, 1996, Pages 63-67

  Guerin V ^a   Delance, V ^a   Papalexiou, P ^b   Duchene P ^c   Houin, G ^d   Thomas, J L ^a  

^a Dept Rech et Devmt Cliniques   (France)

^b COMARA ^*  (Belgium)

^c ADME Bioanalyses   (France)

^d UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

imidazole derivative; pharmacokinetics; radioactivity; vaginal candidosis

Indexed keywords

CARBON 14; SERTACONAZOLE;

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; DRUG ABSORPTION; DRUG ADMINISTRATION; DRUG TOLERANCE; FEMALE; HORMONE SUBSTITUTION; HUMAN; INTRAVAGINAL DRUG ADMINISTRATION; ISOTOPE LABELING; NORMAL HUMAN; POSTMENOPAUSE; SUPPOSITORY; VAGINA CANDIDIASIS;

EID: 0029838696     PISSN: 11565233     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Brugmans J, Van Cutsem J, Heykants J, Schuermans V, Thienpont D. Systemic antifungal potential, safety biotransport and transformation of miconazole nitrate. Eur J Clin Pharmacol 1972;5:93-9.
2. Castello JM. Senaconazole nitrate. Drugs Future 1991;16:213-6.
3. Clissod SP, Heel RC. Tioconazole. A review of its antimicrobiotal activity and therapeutic use in superficial mycoses. Drugs 1986;31:29-51.
4. Heel RC, Brodgen RN, Speight TM, Avery GS. Econazole. A review of its antifungal activity and therapeutic efficacy. Drugs 1978;16:177-201.
5. 3H-fenticonazole after vaginal administration of 1 g in patients. Chemother 1991;3:23-7.
6. Vukovich RA, Heald A, Darragh A. Vaginal absorption of two imidazole antifungal agents, econazole and miconazole. Clin Pharmacol Ther 1977;21:121.